JPH0127043B2 - - Google Patents
Info
- Publication number
- JPH0127043B2 JPH0127043B2 JP19151682A JP19151682A JPH0127043B2 JP H0127043 B2 JPH0127043 B2 JP H0127043B2 JP 19151682 A JP19151682 A JP 19151682A JP 19151682 A JP19151682 A JP 19151682A JP H0127043 B2 JPH0127043 B2 JP H0127043B2
- Authority
- JP
- Japan
- Prior art keywords
- composition
- sorbitol
- glycerin
- xylitol
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 46
- 239000000203 mixture Substances 0.000 claims description 43
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 23
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 23
- 235000011187 glycerol Nutrition 0.000 claims description 23
- 229960002920 sorbitol Drugs 0.000 claims description 23
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 22
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 22
- 239000000811 xylitol Substances 0.000 claims description 22
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 22
- 235000010447 xylitol Nutrition 0.000 claims description 22
- 229960002675 xylitol Drugs 0.000 claims description 22
- 239000004480 active ingredient Substances 0.000 claims description 15
- 229960005150 glycerol Drugs 0.000 claims description 14
- 239000008141 laxative Substances 0.000 claims description 14
- 230000002475 laxative effect Effects 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 230000000694 effects Effects 0.000 description 15
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 229940125722 laxative agent Drugs 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 230000013872 defecation Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 3
- 230000000741 diarrhetic effect Effects 0.000 description 3
- 239000004302 potassium sorbate Substances 0.000 description 3
- 229940069338 potassium sorbate Drugs 0.000 description 3
- 235000010241 potassium sorbate Nutrition 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 241000792859 Enema Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008143 stimulant laxative Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19151682A JPS5980608A (ja) | 1982-10-29 | 1982-10-29 | 透明液状緩下剤組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19151682A JPS5980608A (ja) | 1982-10-29 | 1982-10-29 | 透明液状緩下剤組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5980608A JPS5980608A (ja) | 1984-05-10 |
| JPH0127043B2 true JPH0127043B2 (enrdf_load_stackoverflow) | 1989-05-26 |
Family
ID=16275949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP19151682A Granted JPS5980608A (ja) | 1982-10-29 | 1982-10-29 | 透明液状緩下剤組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5980608A (enrdf_load_stackoverflow) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6200556B1 (en) * | 1996-08-22 | 2001-03-13 | Clive B. Moss | High fibre, low calorie, dietary composition |
| KR101423005B1 (ko) | 2013-10-17 | 2014-07-28 | 강윤식 | 장 세정용 조성물 |
-
1982
- 1982-10-29 JP JP19151682A patent/JPS5980608A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5980608A (ja) | 1984-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3255641B2 (ja) | 胃腸洗剤、若しくは緩下剤として使用する経口投与医薬組成物 | |
| US4145412A (en) | Composition for application to oral cavity and method for preparation thereof | |
| JPH01238528A (ja) | ニフェジピンを含有する即時口腔内放出性カプセル製剤 | |
| Linsman et al. | Fluoride osteosclerosis from drinking water | |
| JP2711759B2 (ja) | 止瀉剤組成物 | |
| US3621094A (en) | Concentrated aqueous liquid antacid compositions containing certain phosphate and gluconate salts | |
| DE69709349T2 (de) | Arzneimittel bestehend aus diclofenac | |
| US2721161A (en) | Ascorbic acid preparation | |
| JPH0127043B2 (enrdf_load_stackoverflow) | ||
| KR880009654A (ko) | 아세트알데히드의 독성을 감소시키는 조성물 및 방법 | |
| US4346082A (en) | Method of employing therapeutic composition comprising ammonium or substituted ammonium compounds for treatment of alcoholism | |
| JP2721929B2 (ja) | 腸管洗浄用組成物 | |
| US2847346A (en) | Laxative compositions contaqining dioctyl sodium sulfosuccinate and 1, 8-dihydroxyanthraquinone | |
| DE2700085A1 (de) | Arzneimittel | |
| EP2931258A2 (de) | Zusammensetzungen und lösungen für die darmreinigung | |
| JPH0563452B2 (enrdf_load_stackoverflow) | ||
| EP0150248B1 (de) | Mittel zur Behandlung und Prophylaxe uratischer und gemischter uratischer Lithiasis | |
| DE60308595T2 (de) | Flüssige Antazida | |
| JP2001106630A (ja) | シメチコンを含む潰瘍性大腸炎治療用組成物 | |
| Tiwari et al. | EVALUATIO OF DIURETIC POTE TIAL OF DRAKSHARISHTA PREPARED BY TRADITIO AL AD MODER METHODS I EXPERIME TAL RATS | |
| BE1000535A4 (fr) | Composition pharmaceutique injectable a base d'amoxicilline. | |
| US2447363A (en) | Compound of urobilinogen and hippuric acid as antipressor | |
| KR980008019A (ko) | 위점막 손상 억제용 음료조성물 | |
| SARGENT et al. | A NEW CONTRAST MEDIUM FOR CHOLANGIO-CHOLECYSTOGRAPHY: MEGLUMINE IODOXAMATE | |
| AU745008C (en) | Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors |